 

1. The Board first issued the Respondent a license to practice medicine in the
State of Maryland on December 29, 2016, under License Number D82725. The
Respondent’s license will expire on September 30, 2021.

2. The Respondent completed a residency training program in anesthesiology.
He has not reported any board certifications or self-designated practice areas to the Board.

3. On or about January 15, 2019, the Respondent self-reported to the Board that
he had been treated for a condition! that involved his use of an intoxicating substance.

4. On or about February 12, 2019, the Respondent provided the Board with a
discharge summary from his treatment provider that detailed his condition as well as the
treatment he received.

5. On or about June 21, 2019, the Board, having obtained the Respondent’s
prior authorization, obtained a copy of records from the Respondent’s treatment provider.
These records confirmed a diagnosis of and ongoing treatment for a specific condition that
involved the use of an intoxicating substance.

6. By letter dated August 16, 2019, the Board directed the Respondent to
contact a Board-approved program (the “Program”) by August 26, 2019, and schedule an
evaluation with the Program.

7. On or about September 3, 2019, the Program received written notice that the
Respondent was unable to complete an evaluation with the Program because was receiving
intensive, ongoing treatment in Virginia for a condition involving the use of an intoxicating

substance.

‘ To maintain confidentiality, the Respondent’s specific condition and treatment that he
received for it will not be described in this Consent Order.

2
